Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension

  • Willems, Ruben
  • Annemans, Lieven
  • Siopis, George
  • Moschonis, George
  • Vedanthan, Rajesh
  • Jung, Jenny
  • Kwasnicka, Dominika
  • Oldenburg, Brian
  • d’Antonio, Claudia
  • Girolami, Sandro
  • Agapidaki, Eirini
  • Manios, Yannis
  • Verhaeghe, Nick
  • Usheva, Natalya
  • Iotova, Violeta
  • Triantafyllidis, Andreas
  • Votis, Konstantinos
  • Toti, Florian
  • Makrilakis, Konstantinos
  • Seghieri, Chiara
  • Moreno, Luis
  • Dupont, Sabine
  • Lewis, Leo
  • Djokic, Djordje
  • Skouteris, Helen
Digital health interventions have been shown to be clinically-effective for type 2 diabetes mellitus (T2DM) and hypertension prevention and treatment. This study synthesizes and compares the cost-effectiveness of text-messaging, smartphone application, and websites by searching CINAHL, Cochrane Central, Embase, Medline and PsycInfo for full economic or cost-minimisation studies of digital health interventions in adults with or at risk of T2DM and/or hypertension. Costs and health effects are synthesised narratively. Study quality appraisal using the Consensus on Health Economic Criteria (CHEC) list results in recommendations for future health economic evaluations of digital health interventions. Of 3056 records identified, 14 studies are included (7 studies applied text-messaging, 4 employed smartphone applications, and 5 used websites). Ten studies are cost-utility analyses: incremental cost-utility ratios (ICUR) vary from dominant to €75,233/quality-adjusted life year (QALY), with a median of €3840/QALY (interquartile range €16,179). One study finds no QALY difference. None of the three digital health intervention modes is associated with substantially better cost-effectiveness. Interventions are consistently cost-effective in populations with (pre)T2DM but not in populations with hypertension. Mean quality score is 63.0% (standard deviation 13.7%). Substandard application of time horizon, sensitivity analysis, and subgroup analysis next to transparency concerns (regarding competing alternatives, perspective, and costing) downgrades quality of evidence. In conclusion, smartphone application, text-messaging, and website-based interventions are cost-effective without substantial differences between the different delivery modes. Future health economic studies should increase transparency, conduct sufficient sensitivity analyses, and appraise the ICUR more critically in light of a reasoned willingness-to-pay threshold.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Addressing chronic diseases: a comparative study of policies towards type-2 diabetes and hypertension in selected European countries

  • Seghieri, Chiara
  • Ferré, Francesca
  • Tortù, Costanza
  • Bertarelli, Gaia
  • Mavrogianni, Christina
  • Usheva, Natalya
  • Toti, Florian
  • Moreno, Luis
  • Agapidaki, Eirini
  • Manios, Yannis
Background Type-2 diabetes (T2D) and hypertension (HTN) are two of the most prevalent non-communicable diseases (NCDs): they both cause a relevant number of premature deaths worldwide and heavily impact the national health systems. This study illustrates the impact of HTN and T2D in four European countries (Albania, Bulgaria, Greece and Spain) and compares their policies towards the monitoring and management of HTN and T2D and the prevention of NCDs as a whole. This analysis is conducted throughout the DigiCare4You Project (H2020)—which implements an innovative solution involving digital tools for the prevention and management of T2D and HTN. Methods The analysis is implemented through desk research, and it is enriched with additional information directly provided by the local coordinators in the four countries, by filling specific semi-structured forms. Results The countries exhibit significant differences in the prevalence of HTN and T2D and available policies and programs targeted to these two chronic conditions. Each country has implemented strategies for HTN and T2D, including prevention initiatives, therapeutic guidelines, educational programs and children's growth monitoring programs. However, patient education on proper disease management needs improvement in all countries, registries about patients affected by HTN and T2D are not always available, and not all countries promoted acts to contain the increasing rates of risk factors related to NCDs. Conclusions While political awareness of the risks associated with HTN, T2D and NCDs in general is growing, there is a collective need for countries to strengthen their policies for preventing and managing these chronic diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Usability and acceptance of a digital screening tool for diabetes in four European countries: the DigiCare4You study

  • Triantafyllidis, Andreas
  • Segkouli, Sofia
  • Skoumpourdi, Katerina
  • Mavrogianni, Christina
  • Doracaj, Ditila
  • Toti, Florian
  • Usheva, Natalya
  • Mirchev, Martin
  • Giménez Legarre, Natalia
  • Reis Maneschy, Ivie
  • Manios, Yannis
  • Votis, Konstantinos
  • Manios, Yannis
  • Seghieri, Chiara
  • Djokic, Djordje
  • Votis, Konstantinos
  • Makrilakis, Konstantinos
  • Willems, Lieven Annemans/Ruben
  • Vedanthan, Rajesh
  • Dupont, Sabine
  • Oldenburg, Brian
  • Kwasnicka, Dominika
  • Gong, Enying
  • Jung, Jenny
  • Asare, Bernard Yeboah-Asiamah
  • Kodithuwakku, Vimarsha
  • Votis, Konstantinos
  • Triantafyllidis, Andreas
  • Segkouli, Sofia
  • Alexiadis, Anastasios
  • Kyparissis, Odysseas
  • Spyrou, Aggeliki
  • Petridis, Panagiotis
  • Tziastas, Christos
  • Skoumpourdi, Katerina
  • Manios, Yannis
  • Anastasiou, Costas
  • Tserpes, Konstantinos
  • Diou, Christos
  • Tsigos, Constantine
  • Mavrogianni, Christina
  • Karaglani, Eva
  • Ntzouvani, Agathi
  • Kontochristopoulou, Katerina
  • Makri, Rafaela
  • Argyropoulou, Matzourana
  • Filippou, Amalia
  • Chrysini, Maria
  • Vervesou, Katerina
  • Roussos, Renos
  • Chrysanthakopoulou, Niovi
  • Lampidi, Thalia
  • Rifioti, Irene
  • Voureka, Olga
  • Terzaki, Renia
  • Pelekanou, Christina
  • Kostarellou, Panayiota
  • Dupont, Sabine
  • Dupont, Elizabeth
  • Boccardo, Martina
  • Girolami, Sandro
  • Vespasiani, Giacomo
  • Almonti, Teresa
  • Pierantozzi, Nazzareno
  • Notts, Eric
  • Stoppaccioli, Giorgia
  • D’Antonio, Claudia
  • Skouteris, Helen
  • Taylor, Tracy
  • Savaglio, Melissa
  • Makrilakis, Konstantinos
  • Stergiou, George
  • Liatis, Stavros
  • Karamanakos, George
  • Koliaki, Chrysi
  • Kollias, Anastasios
  • Zikou, Eva
  • Dimosthenopoulos, Haris
  • Vedanthan, Rajesh
  • Huang, Keng-Yen
  • Adhikari, Samrachana
  • Gjonaj, Jessica
  • Sahito, Farhan
  • Pavlovic, Dusan
  • Djokic, Djordje
  • Sahito, Arzoo
  • Battalova, Gisella
  • Seghieri, Chiara
  • Tortu, Costanza
  • Ferre, Francesca
  • Iotova, Violeta
  • Usheva, Natalya
  • Zlateva, Tanya
  • Tzochev, Kaloyan
  • Yotov, Yoto
  • Chamova, Rosiitsa
  • Kozhuharova, Anna
  • Todorova, Vesela
  • Mitev, Alexander
  • Marinova, Ralitsa
  • Kandilarova, Donika
  • Nedelcheva, Sonya
  • Boncheva, Petya
  • Mirchev, Martin
  • Aznar, Luis Moreno
  • Botaya, Rosa Magallón
  • Lozano, Gloria Bueno
  • Legarre, Natalia
  • Maneschy, Ivie
  • Miguel-Berges, María L.
  • Flores-Barrantes, Paloma
  • Gonzalez-Gil, Esther Ma
  • De Miguel-Etayo, Pilar
  • Blázquez, Bárbara Oliván
  • Pérez, Susana
  • Toti, Florian
  • Doracaj, Ditila
  • Nelaj, Ergita
  • Prifti, Skerdi
  • Bruka, Luftime
  • Lapardhaja, Adriana
  • Laze, Ornela
Digital screening programs and tools provide the potential for early detection of chronic diseases such as diabetes in the general population. The main purpose of the current paper is to present the findings of a multi-country study conducted with implementers (i.e., health professionals) and citizens (i.e., patients) to assess the usability and acceptance of a digital screening tool for type 2 diabetes screening. To this aim, 109 healthcare professionals and 71 citizens from four (4) European countries—Bulgaria, Albania, Spain, and Greece –participated in the study. The participants were requested to test the DigiCare4You tool, by completing instructed activities for user interaction, and were provided with questionnaires consisted of multiple sections that captured participants’ characteristics, perceptions, attitudes, and testing experience. The perceived usability assessed through the System Usability Scale (SUS) was found to be satisfactory for both health professionals (SUS score = 73.9) and citizens (SUS score = 68.06), and the majority of the participants considered the tool as useful and easy to learn. The results show the digital tool’s favorable usability among healthcare professionals and citizens in different regions, paving the way for its successful implementation and wider adoption in diabetes care.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Tailoring mobile health apps for lifestyle management: a discrete choice experiment

  • Seghieri, Chiara
  • Feldens, Tallys
  • Tortù, Costanza
  • Usheva, Natalya
  • Toti, Florian
  • Doracaj, Ditila
  • Giménez-Legarre, Natalia
  • Karaglani, Eva
  • Manios, Yannis
Background: Health apps designed to monitor, motivate, and educate people towards their health goals are getting more users and features each time. These apps offer valuable support for self-managing health behaviors and achieving long-term objectives. However, there is limited understanding of user preferences regarding essential app features. The aim of the study is to get insights about potential users’ preferences, in order to tailor better apps for lifestyle management. Methods: We conducted a three-part web survey with 389 respondents from four countries as part of the DigiCare4You European Union (EU) project. In the first part, we collected the socioeconomic characteristics and health status of each respondent. In the following stage, we asked five questions on a Likert scale to ascertain the individual level of usage and general attitude towards technology. Finally, we performed a discrete choice experiment (DCE) using an unlabeled design and estimated the odds ratio for each feature using conditional logit analysis. We also ran alternative estimations stratifying by non-communicable disease (NCD) patients and non-NCD patients, and explored latent profile analysis (LPA) to understand whether the general attitude towards technology impacts the preference pattern between users. Results: The DCE revealed that respondents showed a clear preference for monitoring physical health over emotional status. They favored receiving lifestyle achievement notifications weekly rather than daily, and daily rather than more frequently. Similarly, respondents preferred uploading body weight measurements on a weekly or monthly basis rather than daily. Users expressed a preference for collaborating with their doctors to set exercise and diet goals, rather than either deciding independently or delegating entirely to their doctors. End-users also show a pattern of preferring notifications for goals instead of challenging other users. Preferences regarding the subjects of health content between workout routines, food recipes, and new scientific evidence were not significant; also, no statistical significance was found for the decision between follow-up visits with their doctor in person or remotely. LPA returned two groups regarding their general attitude towards technology: a lower, an intermediate, and a higher usage in their private life based on their responses to the questionnaire. Stratified DCEs have shown heterogeneity of users’ preferences according to their specific attitude towards technology. Conclusions: Our study indicates that potential mobile health (mHealth) app users managing chronic conditions prefer platforms that enable shared responsibility with their doctors in defining health goals while having an intermediate level of interaction frequency with the app. These findings are key to tailoring mHealth apps that can optimize motivation triggers, support healthier lifestyles, and empower patients with chronic conditions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The revised-FINDRISC: A tool for type 2 diabetes risk screening across diverse populations incorporating sociodemographic indicators

  • Vitoratou, Dimitra-Irinna
  • Dimakopoulou, Konstantina
  • Mavrogianni, Christina
  • Karaglani, Eva
  • Argyropoulou, Matzourana
  • Cardon, Greet
  • Usheva, Natalya
  • Iotova, Violeta
  • Tankova, Tsvetalina
  • Giménez-Legarre, Natalia
  • Moreno, Luis A.
  • Toti, Florian
  • Makrilakis, Konstantinos
  • Doracaj, Ditila
  • Imre, Rurik
  • Torzsa, Péter
  • Lindström, Jaana
  • Panagiotakos, Demosthenes
  • Manios, Yannis
Aim Τo develop a revised version of the FINDRISC tailored to improve the identification of individuals at high risk for type 2 diabetes (T2D) across diverse populations. Methods The revised-FINDRISC was developed using pooled harmonized baseline data from the multinational Feel4Diabetes (NCT02393872; N = 3526) and DigiCare4You (NCT05648383; N = 2156) studies. Validation utilized data from the 20-year ATTICA cohort study in Greece. Original FINDRISC components were analyzed using Fisher’s Linear Discriminant Analysis followed by supervised stepwise logistic regression to identify significant T2D cross-sectional predictors. The revised-FINDRISC was developed by re-scoring or excluding original items and incorporating new predictors, generating an integer-based score to enhance usability. Results The revised-FINDRISC significantly improved accuracy in identifying current T2D risk over the original, with an overall AUC of 0.911(95%CI: 0.901,0.922) versus 0.832(0.815,0.846). When stratified by country economic classification, the revised score outperformed the original across all groups: LMICs: 0.881(0.864,0.898) vs. 0.815(0.793,0.837), South European-HICs: 0.891(0.867,0.916) vs. 0.839(0.811,0.869), and North European-HICs: 0.921(0.872,0.971) vs. 0.844(0.742,0.949). A clinical threshold score of 13/24 in the revised-FINDRISC offers optimal sensitivity and specificity for identifying individuals at risk of T2D. Conclusion Enhanced with demographic, socio-economic, and clinical factors, the revised-FINDRISC potentially represents a substantive advancement in T2D screening, supporting early detection and targeted prevention.